SCHEMBL6345905

SCHEMBL6345905

O=C(O)c1nccnc1C(=O)O.[NaH].[NaH]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.52
MAPT P10636 5/20 0.52
ALDH1A1 P00352 4/20 0.52
TSHR P16473 3/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
ALOX15 P16050 2/20 0.52
CYP3A4 P08684 1/20 0.52
BLM P54132 1/20 0.52
AGER Q15109 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
ASPH Q12797 1/20 0.48
KDM8 Q8N371 1/20 0.48
CYP1A2 P05177 1/20 0.45
KMT2A Q03164 2/20 0.44
ATM Q13315 1/20 0.44
NAPRT Q6XQN6 3/20 0.44
HCAR2 Q8TDS4 1/20 0.44
MYC P01106 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69939 0.97 KDM4E (0.54) KDM4EMAPTALDH1A1TSHRL3MBTL1
SCHEMBL27875395 0.94 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
SCHEMBL28058447 0.94 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
Water SCHEMBL335807 0.94 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
Hydrochloric Acid SCHEMBL9356773 0.94 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
Hydrochloric Acid SCHEMBL9356765 0.94 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
SCHEMBL29113117 0.94 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
Iodide SCHEMBL28827358 0.91 KDM4E (0.52) KDM4EMAPTALDH1A1TSHRL3MBTL1
Formic Acid SCHEMBL27879436 0.86 KDM4E (0.46) KDM4EMAPTALDH1A1TSHRL3MBTL1
SCHEMBL9630721 0.86 KDM4E (0.48) KDM4EMAPTALDH1A1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6916816-B2 Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2005-07-12 US disclosed
EP-1244638-B1 PHENANTHRYL PIPERAZINYL DICARBOXYLIC ACIDS AS SELECTIVE NMDA RECEPTOR MODULATING AGENTS UNIV BRISTOL (GB) 2004-05-12 EP disclosed
US-20030078237-A1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents US ARMY, SECRETARY OF THE ARMY 2003-04-24 US disclosed
EP-1244638-A2 PHENANTHRYL PIPERAZINYL DICARBOXYLIC ACIDS AS SELECTIVE NMDA RECEPTOR MODULATING AGENTS UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) 2002-10-02 EP disclosed
WO-2001044205-A2 PHENANTHRYL PIPERAZINYL DICARBOXYLIC ACIDS AS SELECTIVE NMDA RECEPTOR MODULATING AGENTS UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) 2001-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078237-A1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents GRIK2, GRIK3, GRIK5 KDM4E 2004/4885MAPT 4540/4885ALDH1A1 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.